Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ResCure™ in COVID-19 Infection
NCT04395716Phase 1Withdrawn
- Sponsor
- ProgenaBiome
- Start
- Jan 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ResCure in coronavirus disease 2019 (COVID-19), sponsored by ProgenaBiome. Primary endpoints: Rate of recovery of mild or moderate COVID-19 at 12 weeks, Reduction or progression of symptomatic days at 12 weeks and 4 more. Planned start Jan 2020; status: withdrawn.
02
Drugs
ResCure
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04395716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04395716.